So I proposed this post hoc analysis to look at more of the totality of effects of these two drugs using a six-component composite end point. The six components were all-cause mortality, MI, stroke, coronary revascularization, hospitalization for heart failure and a composite of adverse renal outcomes
4 This exceeded the results of the SURMOUNT-1 clinical trial, suggesting that comprehensive behavioural support may enhance medication outcomes
Patients should inform their healthcare provider about all medications and supplements they are taking to ensure appropriate monitoring and adjustment of doses if needed
Food-Grade Mulberry Powder Enriched with 1-Deoxynojirimycin Suppresses the Elevation of Postprandial Blood Glucose in Humans
Astrup A, Carraro R, Finer N, Harper A, Kunesova M, Lean ME, Niskanen L, Rasmussen MF, Rissanen A, Rossner S, Savolainen MJ, Van Gaal L, Investigators NN (2012) Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide